Registration Update
We have reached the maximum number of registered attendees for this event. New registrations will be placed on a waitlist, and confirmations will be sent on a rolling basis if spots become available.
Please note: Walk-in attendees will not be admitted without prior confirmation.
Please contact, Wendi Xiang:
Email: wxiang@yafocapital.com
Email: wxiang@yafocapital.com
For more YAFO ACCESS Asia BD Forum @ JPM updates, follow us on our LinkedIn Page and WeChat by scanning the QR Code below:
See Frequently Asked Questions
MAKE THE MOVE NOW— POSITION YOURSELF BEFORE JPM
For Global Pharma & Investors
Even if your participation plans are still being finalized, attending the ACCESS ASIA BD Forum @ JPM 2026 offers access to insights directly from emerging innovators. All attendees will be able to review available assets via the shared link.
If an asset aligns with your strategy, YAFO may help facilitate an introductory call with the respective company, subject to mutual interest.
👉 In-person attendance enables a deeper perspective — with the chance to hear, network, and engage directly with executives from high-profile biotech companies, global pharma, and leading investment firms.
For Asia-Based Biotech Innovators
If you’re considering participation, the Forum is an opportunity to strengthen visibility in front of global strategic stakeholders. While 1-on-1 meetings are exclusively organized for YAFO clients, attendees may access the asset list and signal interest.
Where relevant, YAFO can support potential follow-up discussions with our clients.
👉 ACCESS ASIA also provides a platform to connect directly with decision-makers from established global organizations — through keynote sessions, networking exchanges, and moderated discussions.
BioToChina.org 